Table 1.
General characteristics of the study cohort (n = 310) stratified by 90-day survivors and non-survivors
Variable | 90-day survivors (n = 251) | 90-day non-survivors (n = 59) | P value |
---|---|---|---|
Age (years) | 67 ± 14 | 69 ± 18 | 0.43 |
Sex (%) | 0.15 | ||
Female | 39 | 49 | |
Male | 61 | 51 | |
Race (%) | <0.001 | ||
Non-white | 5 | 32 | |
White | 95 | 68 | |
BMI (kg/m2) | 28 ± 7 | 30 ± 8 | 0.08 |
Type of patient (%) | <0.001 | ||
Surgical | 76 | 43 | |
Medical | 24 | 57 | |
25OHD (ng/mL) | 20 ± 14 | 12 ± 7 | <0.001 |
APACHE II | 14 ± 7 | 24 ± 9 | <0.001 |
Comorbidities (%) | 0.21 | ||
Cardiovascular | 92 | 97 | |
Pulmonary | 24 | 46 | |
Renal | 35 | 44 | |
Hepatic | 5 | 12 | |
Sepsis | 38 | 51 | |
Trauma | 20 | 36 | |
DCCI | 3 ± 2 | 5 ± 3 | <0.001 |
Continuous data were reported as means with standard deviations (SDs), medians with interquartile ranges (IQRs), and categorical values were expressed as proportions. Body mass index = BMI, Acute Physiology and Chronic Health Evaluation II = APACHE II; Deyo-Charlson Comorbidity Index = DCCI; intensive care unit = ICU
P-values in italics represent statistically significant results